Philip J. Boyne, DMD, MS, DSc was a world-famous oral and maxillofacial surgeon, dental implantologist, biological innovator, and bone physiologist at Loma Linda University.
Simon Young, DDS, MD, PhD
Development of a Compromised Maxillofacial Wound Healing Model for Bone Graft Evaluation
Dr. Jasjit Dillon
Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ): A Prospective, Randomized Controlled Trial to Evaluate a Novel Non-Operative Treatment
The right professional development can mean all the difference in one’s career and in bringing about improved outcomes for patients.
Fujifilm Global and Takeda Oncology recently announced a collaboration to develop regenerative medicine therapies for the treatment of heart failure using induced pluripotent stem cell (iPSC)-derived cardiomyocytes.
The University of Florida has launched a Center for Regenerative Medicine to develop lifesaving therapies “to heal the body from within” using stem cells that repair damaged tissue and organs.
Sidney Eisig, DDS
Tracking Cells and Biomaterials Remodeling in Tissue Engineered Bone Grafts
Pamela Yelick, PhD
Biphasic Scaffolds for Alveolar Bone and Tooth Regeneration
A method of making bioink droplets to stick to each other using an enzyme driven crosslinking method has been developed by researchers from Osaka University
Since 2010 global demographics have revealed an ever-increasing elderly population.
Aged patients, who tend to present with partial or total tooth loss, inevitably need more complex and higher quality dental rehabilitation, including dental implant therapy.
Jaw Surgery is performed to correct various problems related to the jaw, facial appearance, and other maxillofacial problems.
Bone is comprised of a mineral and protein scaffold filled with bone cells.
Bisphosphonates and other antiresorptives have been used in various bone diseases for many years.
This weekend, Osteo Science Foundation held their first independent educational event in Miami, Florida.
This spring, Osteo Science Foundation’s Board of Directors is excited to announce three brand-new programs, two of which are offered exclusively for Oral and CranioMaxillofacial surgery residents.
It is with deep sadness that we mourn the passing of our founder: a unique person, pioneering entrepreneur and visionary whose dedication to regenerative medicine led to the creation of the Osteo Science Foundation.
The Board of Directors of Osteo Science Foundation has awarded its inaugural four research grants, totaling close to $200,000, to researchers at Columbia University, Indiana University, Rutgers University and UCLA.
In October 2013, Dr. Peter Geistlich, the President of the Board of Directors of Geistlich Pharma AG, together with Geistlich Pharma AG in the USA, launched the Osteo Science Foundation which has its registered office in Philadelphia.